Julia Belluz

@juliaoftoronto · Paris, France · joined 20 Sep 2009

Health journalist, contributing opinion writer @nytimes. Formerly @voxdotcom, @MIT Knight Fellow etc. juliabelluz@bsky.social Book: https://t.co/F0UrpthF3C

33 489Followers

2 908Following

17 468Posts total

82.9KViews on collected posts

Derniers posts

Julia Belluz@juliaoftoronto29 Jul

@juliaoftoronto @nytopinion I just looked you and @KevinH_PhD up. I see why you hate the entire health space now. If the gut microbiome is bs, how do you explain all the differences with UPFs? How do you also explain all the studies? You act like it hasn’t been proven many times 20 views · 0 likes · 0 reposts · 0 replies Open on X →

Julia Belluz@juliaoftoronto29 Jul

@juliaoftoronto @nytopinion You strain so as not to give the GOP credit for anything, when if you truly cared you’d be trying to build allies. They have gone after soda on food stamps for instance. 13 views · 0 likes · 0 reposts · 0 replies Open on X →

Julia Belluz@juliaoftoronto28 Jul

@juliaoftoronto @nytopinion I’m all for gardening my own greens these days. Pretty much all I e got ready to pick is parsley. Vitamin K for the win! 52 views · 0 likes · 0 reposts · 0 replies Open on X →

Julia Belluz@juliaoftoronto27 Jul

For decades, ppl have talked about the toxic food environment and how it’s stacked against most people. For decades, little’s changed policy-wise. I increasingly think there’s only one way out. That way is litigation. https://t.co/pXtFw01PVG @nytopinion 8.1K views · 21 likes · 7 reposts · 3 replies Open on X →

Julia Belluz@juliaoftoronto26 Jul

@juliaoftoronto @nytopinion Now talk about the 10,000 food additives the FDA has no problem with that are slowly poisoning an entire population. 254 views · 8 likes · 0 reposts · 1 replies Open on X →

Julia Belluz@juliaoftoronto26 Jul

@juliaoftoronto @nytopinion How much did big pharma pay you to write this article? 4.2K views · 82 likes · 0 reposts · 5 replies Open on X →

Julia Belluz@juliaoftoronto26 Jul

@juliaoftoronto @nytopinion Just making sure you saw this re-post, Julia. 613 views · 7 likes · 0 reposts · 0 replies Open on X →

Julia Belluz@juliaoftoronto26 Jul

Let me help you with your hook: *Millions of** Americans **are** injecting unproven chemicals **from the Chinese black market**. An FDA advisory panel voted to **move a process forward that will** make it easier for patients to access six experimental #peptides **from a licensed 9.3K views · 54 likes · 3 reposts · 12 replies Open on X →

Julia Belluz@juliaoftoronto25 Jul

Americans want to inject unproven chemicals. They may soon get their way. An FDA advisory meeting voted to make it easier to access six experimental #peptides. But the meeting was never just about peptides. I wrote about why for @nytopinion https://t.co/NjI5yyKMLz 50.5K views · 40 likes · 17 reposts · 18 replies Open on X →

Julia Belluz@juliaoftoronto24 Jul

Until #GLP1s, there's never been a drug states have so completely lost control over. I spoke to Apple News In Conversation about what this tells us about our health system, how it needs to change, and more. You can listen here. https://t.co/ZqRRFOuNDO https://t.co/Jm9bfjVUWv 1.2K views · 10 likes · 0 reposts · 1 replies Open on X →

Julia Belluz@juliaoftoronto8 May

#GLP1s like #Ozempic come as close to wonder drugs as perhaps we've ever had. They're also meeting a really weird moment: the wellness and appearance obsessed algorithmic age @ezraklein and I talked about these two things colliding. Weirdness ensues. https://t.co/LxUZxWnlIM ht 3.9K views · 35 likes · 1 reposts · 7 replies Open on X →

Julia Belluz@juliaoftoronto6 May

A few years back, the @AmerAcadPeds recommended more intensive medical intervention for kids with obesity, including GLP-1s. T he question now is not whether we should give these drugs to kids. It's: why are we even here? My latest @nytopinion https://t.co/qPQcCrdf8M 4.8K views · 5 likes · 2 reposts · 2 replies Open on X →

Face aux comptes de taille comparable

9 posts des 90 derniers jours, à côté de la tranche de 10K–100K abonnés. en dessous de ses pairs à la fois en portée et en engagement.

Vues médianes613ce compte924médiane pour 10K–100K

Portée, %1.83%ce compte3.62%médiane pour 10K–100K

Engagement, %0.43%ce compte1.52%médiane pour 10K–100K

Indicateur	Ce compte	Médiane pour 10K–100K	Rapport
Vues médianes par post	613	924	0.66×
Portée (vues ÷ abonnés)	1.83%	3.62%	0.51×
Taux d'engagement	0.43%	1.52%	0.28×

Autres comptes de cette tranche → Comparer avec un autre compte → Comment ces repères sont établis →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

4.8K6 May

3.9K8 May

1.2K24 Jul

50.5K25 Jul

9.3K26 Jul

613

4.2K

254

8.1K27 Jul

5228 Jul

1329 Jul

Last 12 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.23%6 May

1.09%8 May

1.02%24 Jul

0.17%25 Jul

0.76%26 Jul

1.14%

2.09%

3.54%

0.43%27 Jul

0.00%28 Jul

0.00%29 Jul

0.00%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes64.2%262 in total

Reposts7.4%30 in total

Replies12.0%49 in total

Quotes4.4%18 in total

Bookmarks12.0%49 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Derniers posts

Face aux comptes de taille comparable

Growth & engagement

Views per post

Engagement rate per post

What the audience does

Comptes similaires